The FDA has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of WAS.
Most people in the United States are happy with their health insurance, but many still struggle with denied claims, delays and rising costs.
Nearly one in 10 adolescent and young adult patients diagnosed with nonmetastatic cancer later develop metastatic recurrence.
South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback